Protein A (PA) of Staphylococcus aureus is known as an immunomodulator, In
a search of the molecular mechanism(s) of PA-induced immunocyte potentiatio
n, we found dose-dependent binding of PA (0.01 to 100 mu g/ml PA) to the mi
ce splenic lymphocytes. Interestingly, treatment of 1 mu g PA/20 g mice inc
reased the splenic lymphocyte number similar to 5-fold over control but at
a 10-mu g dose the cell number was decreased compared with a 1-mu g dose. F
low cytometric analysis of cell-cycle phase distribution of nuclear DNA in
splenic lymphocytes showed that at a 1-mu g dose, PA shifted the cell-cycle
phases from G0/G1 to S and G2/M supporting the pro-proliferative role of P
A. In contrast, the same inducer increased the sub-G1 cell population at a
10-mu g dose indicating the breakdown of cellular DNA These findings were s
upported by DNA ladder formation and nuclear breakdown at this higher dose.
Further studies revealed that at a 1-mu g dose, the level of the pro-proli
ferative/anti-apoptotic protein bcl-2 was increased in splenic lymphocytes
whereas at a 10-mu g dose it showed a decreasing trend. In contrast, concen
trations of proapoptotic proteins, p53 and bar, were increased at a 10-mu g
dose. A search of the mechanism(s) of such differential action of PA at th
ese two doses revealed that the lower dose of PA upregulated the production
of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha
) to the extent which has already been reported by our laboratory to be ben
eficial to the host. However, at a larger dose, much higher release of TNF-
alpha and interleukin-2 (IL-2) may account for the apoptosis of splenic cel
ls. All these findings indicated that the cross-talk between all these pro-
and anti-apoptotic factors may contribute to maintain a balance between gr
owth and death of cells and may be one bf the important factors deciding wh
ether a cell would follow a proliferative pathway or an apoptotic pathway.
(C) 1999 Academic Press.